What Is Plantar Fat Pad Atrophy?
Plantar fat pad atrophy is a degenerative condition characterized by progressive loss of thickness and viscoelastic properties of the heel fat pad — a specialized structure that works as a natural "shock absorber", absorbing the impact of gait and protecting the calcaneus bone and the underlying soft tissues.
The heel fat pad is a highly organized structure of adipose tissue chambers separated by fibroelastic septa containing collagen and elastic fibers. This "honeycomb" architecture lets it absorb forces of up to 3 times body weight during gait and 5-7 times during running.
When the fat pad atrophies — through aging, repeated corticosteroid injections, or other causes — the calcaneus loses its mechanical protection. The patient feels as if "stepping on bone," with diffuse plantar heel pain that worsens on hard surfaces and is relieved by cushioned footwear.
Natural Shock Absorber
The fat pad absorbs impacts of 3-7x body weight. When it atrophies, the calcaneus is exposed to direct mechanical forces.
Confused With Fasciitis
Frequently misdiagnosed as plantar fasciitis. The treatment is different — stretching does not help.
Corticosteroid as a Cause
Repeated corticosteroid injections in the heel can cause iatrogenic fat pad atrophy.
Epidemiology
Plantar fat pad atrophy is a frequently underdiagnosed cause of heel pain. Prevalence increases significantly with age and is identifiable on ultrasound in up to 30-40% of individuals over 60. It is more common in patients who are obese, have diabetes, or have received repeated corticosteroid injections.
Risk factors include: aging (the most common cause — natural loss of adipose tissue and degeneration of fibrous septa), repeated corticosteroid injections in the heel (iatrogenic cause), diabetes mellitus (microangiopathy and neuropathy compromise fat pad nutrition), rheumatoid arthritis (systemic inflammation of fibrous septa), obesity (chronic mechanical overload), and prolonged use of rigid, uncushioned footwear.
Pathophysiology
The heel fat pad has a unique architecture. It consists of macro- and microchambers of specialized adipose tissue separated by fibroelastic septa of type I and III collagen interspersed with elastic fibers. This "honeycomb" structure gives it viscoelastic properties — it absorbs energy on impact and returns to its original shape.
FAT PAD COMPONENTS AND CHANGES IN ATROPHY
| COMPONENT | NORMAL FUNCTION | CHANGE IN ATROPHY | CLINICAL CONSEQUENCE |
|---|---|---|---|
| Adipose macrochambers | High-energy impact absorption | Volume reduction, fat loss | Direct impact transmission to the calcaneus |
| Adipose microchambers | Low-energy impact absorption | Chamber fusion and collapse | Loss of fine cushioning |
| Fibrous septa (collagen) | Structural support of chambers | Fragmentation, degeneration | Loss of elasticity and resilience |
| Elastic fibers | Return to original shape after deformation | Degeneration and calcification | Permanent deformation under load |
With aging, there is a reduction in adipose content (loss of up to 50% of volume after age 70), degeneration of fibrous septa with collagen fragmentation and loss of elastic fibers, and reduced vascularization. The fat pad loses its ability to absorb impact and to return elastically.
In corticosteroid-induced cases, direct lipolysis reduces adipose volume and the corticosteroid's anti-anabolic action degrades the septal collagen fibers. The result is a thin, firm, inelastic fat pad — unable to protect the calcaneus during gait.
Symptoms
Symptoms are predominantly mechanical — pain directly related to heel load, without the typical morning component of plantar fasciitis and without a neuropathic component.
Characteristic Symptoms
- 01
Pain in the central plantar heel (not medial as in fasciitis)
- 02
Sensation of "stepping on the bone" or "stepping on a stone"
- 03
Pain that worsens on hard surfaces and improves with cushioned footwear
- 04
Pain that increases throughout the day with standing activity
- 05
Palpation of the calcaneal tubercle directly under the skin (no cushion)
- 06
No first-step pain in the morning (unlike fasciitis)
- 07
Relief when stepping on soft surfaces (carpet, grass)
Diagnosis
Diagnosis is clinical and confirmed by ultrasound, which objectively measures fat pad thickness. The correlation between reduced thickness and clinical symptoms is the diagnostic basis.
🏥Diagnostic Criteria
- 1.Load-related pain in the central plantar heel, with no first-step pattern
- 2.Palpation of the calcaneal tubercle directly under the skin (thin or absent fat pad)
- 3.Loaded ultrasound: fat pad thickness < 12 mm (normal: 15-20 mm)
- 4.No plantar fascia thickening on ultrasound (excludes fasciitis)
- 5.History: advanced age, prior corticosteroid injections, or metabolic risk factors
Ultrasound is the test of choice and should be performed with the patient bearing weight on the foot (loaded). Normal fat pad thickness under load is 15-20 mm; values below 12 mm are suggestive of significant atrophy. Ultrasound elastography is an emerging technique that assesses tissue stiffness — atrophied fat pads are significantly stiffer.
MRI can complement the workup by showing reduced fatty signal in the fat pad (on T1) and, occasionally, calcaneal bone marrow edema from direct overload. However, loaded ultrasound is more practical and accessible for this indication.
DIAGNOSTIC COMPARISON: PLANTAR FASCIITIS VS FAT PAD ATROPHY
| FEATURE | PLANTAR FASCIITIS | FAT PAD ATROPHY |
|---|---|---|
| Pain location | Medial plantar aspect (fascia origin) | Central plantar aspect of the heel |
| Pain pattern | Worse in the first steps in the morning | Worsens throughout the day with load |
| Palpation | Pain at the medial calcaneal tubercle | Thin fat pad — bone palpable directly |
| Ultrasound | Thickened fascia (> 4 mm) | Thin fat pad (< 12 mm loaded) |
| Main treatment | Stretching, supportive insole | Cushioned insole, footwear |
| Typical age range | 40-60 years | > 60 years |
Differential Diagnosis
Plantar heel pain has multiple causes that frequently coexist. Fat pad atrophy can occur alongside plantar fasciitis, especially in elderly patients.
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Plantar fasciitis
Degeneration of the plantar fascia at its calcaneal origin. Typical morning first-step pain.
Calcaneal stress fracture
Bone injury from repetitive microtrauma. Diffuse heel pain in runners.
Tarsal tunnel syndrome
Posterior tibial nerve compression. Neuropathic pain on the sole.
Mortons neuroma
Compressive neuropathy of the intermetatarsal digital nerve. Forefoot pain.
Severs disease (children/adolescents)
Traction apophysitis of the calcaneus at the Achilles tendon insertion.
Treatments
Treatment is predominantly conservative and focused on mechanically replacing the protective function of the atrophied fat pad, since regeneration of the degenerated adipose tissue is limited. Cushioned insoles and proper footwear are the foundation of treatment.
TREATMENT OPTIONS FOR FAT PAD ATROPHY
| TREATMENT | MECHANISM | EVIDENCE | INDICATION |
|---|---|---|---|
| Insole with heel cushioning | Replaces shock absorption function | Moderate to strong | First line — all cases |
| Footwear with cushioned sole | Reduces impact transmission to the calcaneus | Consensus | Complementary to insole |
| Silicone or gel heel cup | Focal cushioning on the heel | Moderate | Simple and accessible alternative |
| Functional taping | Repositions the remaining fat pad under the heel | Weak to moderate | Diagnostic test and temporary relief |
| Acupuncture / Laser therapy | Analgesia, inflammatory modulation | Emerging | Adjunct — pain control |
| Autologous fat grafting | Restoration of adipose volume | Emerging | Severe refractory cases — experimental |
Insoles and Heel Cups
The ideal insole for fat pad atrophy must have specific heel cushioning (gel, silicone, viscoelastic foam, or Poron) with a minimum thickness of 6-8 mm in the heel region. Unlike plantar fasciitis, where the insole needs arch support, in fat pad atrophy the focus is cushioning, not support.
Functional taping is a useful diagnostic test: apply adhesive tape around the heel to "compress" the remaining fat pad and center it under the calcaneal tubercle. If pain improves significantly with taping, this confirms the diagnosis and indicates that an insole will be effective.
Acupuncture as Treatment
Acupuncture plays an adjunctive role in treating fat pad atrophy, addressing pain control and inflammatory modulation. It is especially relevant as an alternative to corticosteroid injection — an option contraindicated in this condition because it worsens atrophy.
Proposed mechanisms — largely supported by experimental studies — include possible release of endogenous opioids for analgesia, modulation of pro-inflammatory cytokines in the periosteum of the overloaded calcaneus (TNF-alpha, IL-6), improved local microcirculation, and effects on peripheral sensitization of nociceptors. A potential trophic effect on the remaining fat pad is hypothetical and not clinically established.
Electroacupuncture with alternating frequencies (2/100 Hz) at pericalcaneal points is particularly useful for chronic pain control. The combination of low and high frequency simultaneously activates the endogenous opioid systems mediated by enkephalins (2 Hz) and dynorphins (100 Hz).
Laser Therapy (Photobiomodulation)
Laser therapy applied to the plantar heel offers analgesic and potentially trophic effects on the remaining tissue. The mechanism involves stimulating mitochondrial cytochrome c oxidase, which increases ATP production in adipocytes and fibroblasts of the fibrous septa.
Experimental studies suggest that photobiomodulation may stimulate preadipocyte proliferation and collagen synthesis in the fibrous septa, with potential to limit atrophy progression. Combining acupuncture with laser therapy offers a safe analgesic alternative that does not cause additional tissue atrophy.
Prognosis
Fat pad atrophy is a chronic, progressive condition. Regeneration of the degenerated adipose tissue is limited, but adequate symptom control allows an active life with good quality. The focus is long-term management, not a definitive cure.
Management Plan
Phase 1
0-2 weeksDiagnosis and Immediate Protection
Confirm with loaded ultrasound. Silicone/gel heel cup for immediate relief. Counsel on proper footwear and avoiding barefoot walking.
Phase 2
2-6 weeksCustom Insole and Pain Control
Fabricate an insole with targeted heel cushioning. Acupuncture and laser therapy for pain control. Functional taping as an adjunct.
Phase 3
1-3 monthsAdaptation and Optimization
Fine-tune the insole based on patient feedback. Adjust activity level with proper footwear.
Phase 4
PermanentLong-Term Maintenance
Ongoing use of a cushioned insole and proper footwear. Replace the insole periodically (every 6-12 months). Acupuncture maintenance sessions as needed.
Myths and Facts
Myth vs. Fact
Fat pad atrophy and plantar fasciitis are the same thing.
They are distinct conditions with different mechanisms, symptoms, and treatments. Fasciitis involves the plantar fascia; atrophy involves the heel's protective adipose tissue.
Stretching the plantar fascia helps with fat pad atrophy.
Stretching has no effect on fat pad atrophy. The main treatment is external mechanical cushioning (insole, footwear).
Corticosteroid injection is a good treatment for the pain.
Corticosteroids cause lipolysis and destroy the fibrous septa, worsening atrophy. They are contraindicated in this condition — acupuncture is a preferable alternative.
The fat pad can fully regenerate.
Regeneration is limited, especially when fibrous septa degeneration is advanced. Management is chronic, focused on replacing the protective function with a proper insole.
When to Seek Medical Care
Frequently Asked Questions About Plantar Fat Pad Atrophy
It is the progressive loss of thickness and cushioning properties of the heel fat pad — a structure that normally absorbs 3-7 times body weight during gait. With atrophy, the calcaneus loses mechanical protection and the patient feels as if "stepping on the bone". Causes include aging, repeated corticosteroid injections, diabetes, and rheumatoid arthritis.
They are distinct conditions. Plantar fasciitis causes medial heel pain, worse with the first morning steps, with thickened fascia on ultrasound. Fat pad atrophy causes central heel pain that worsens throughout the day with load, with a thin fat pad on ultrasound (< 12 mm loaded). In fasciitis, the main treatment is stretching; in atrophy, it is mechanical cushioning with an insole.
Yes. Studies show that 3 or more corticosteroid injections in the heel significantly reduce fat pad thickness. The corticosteroid causes adipocyte lipolysis and degrades the fibrous septa, compromising shock absorption capacity. Iatrogenic atrophy can be partially irreversible. Further injections are contraindicated once atrophy is established.
Treatment focuses on replacing the fat pad's protective function: an insole with heel cushioning (gel, silicone, viscoelastic foam), footwear with a thick, cushioned sole, and avoiding barefoot walking on hard surfaces. Acupuncture and laser therapy control pain without causing further atrophy. Functional taping repositions the remaining fat pad. Autologous fat grafting is an experimental technique for severe cases.
Acupuncture can serve as a non-pharmacological alternative for pain control when further corticosteroid injections are formally discouraged. Proposed mechanisms — release of endogenous opioids, modulation of pro-inflammatory cytokines in the overloaded periosteum, and improved local microcirculation — are supported by experimental studies. For laser therapy, preliminary evidence suggests an effect on preadipocytes and fibroblasts; whether it limits atrophy progression remains a hypothesis under investigation.
Full regeneration of the degenerated fat pad is limited, especially when the fibrous septa are compromised. Management is chronic: a cushioned insole, proper footwear, and avoiding barefoot walking are permanent measures. With adequate treatment, most patients achieve satisfactory pain control and maintain good functional activity. Prevention (avoiding repeated corticosteroid injections) is the best strategy.
The ideal insole has dedicated heel cushioning at least 6-8 mm thick, using materials such as gel, medical silicone, or viscoelastic foam (Poron). The focus is cushioning, not arch support. Silicone heel cups are a practical, accessible alternative. Footwear should have a thick, soft sole with a drop of 8-10 mm. Replace the insole every 6-12 months depending on wear.
Consult an orthopedic physician if heel pain persists for more than 3-4 weeks, if treatment for plantar fasciitis is not working, if you feel as if "stepping on the bone", or if you have a history of repeated corticosteroid injections. Loaded ultrasound is a simple test that distinguishes plantar fasciitis from fat pad atrophy and guides the correct treatment for each condition.
Related Reading
Deepen your knowledge with related articles